{"name":"ScandiBio Therapeutics AB","slug":"scandibio-therapeutics-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Combined metabolic activators","genericName":"Combined metabolic activators","slug":"combined-metabolic-activators","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Combined metabolic activators","genericName":"Combined metabolic activators","slug":"combined-metabolic-activators","phase":"phase_3","mechanism":"Combined metabolic activators enhance cellular energy production and metabolic efficiency by simultaneously activating multiple metabolic pathways.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQcU5UY1NhTTc4Vk9XOVBrbXhXZ2J6UGZxWUhIbWNVcmhEMld2a1JOa2htRUR6TUdDamxVcndCay1wY2Qyclg4ejZBcHpwbXk2QVg2aWgtdEw2V1ZZZXBUU3RmOWNDNFZDYThrSG0wUWhURU5VLWVyYmRtR0JKT0RHU2t3bWtGdEJrOVhxZVhWUTZmTi1fMjZmS1d6MmxHMVRZQ2xoRzlBNUtTcXY5T01QUUZCRV9JVVdpODJOWENzeTBaVkRScFpZcWNnYkFYMWxyQVpCNDlsbURDbFYwTGlybDlHRERibXpPS0Y3RmJrOA?oc=5","date":"2025-11-04","type":"trial","source":"Cision News","summary":"ScandiBio Therapeutics AB Announces Initiation of Phase 3 Clinical Trial of Combined Metabolic Activators (CMA) for Alzheimer’s Disease - Cision News","headline":"ScandiBio Therapeutics AB Announces Initiation of Phase 3 Clinical Trial of Combined Metabolic Activators (CMA) for Alzh","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}